The DONNA Mission is to passionately raise funds for ground breaking breast cancer research and women living with breast cancer. Join us for the 10th Anniversary Marathon Weekend:
Feb 10 – 12, 2017 Learn more
Closer to the Finish! DONNA partner TapImmune issued an update to shareholders September 6 announcing the commencement of enrollment of patients in Q4 2016 for the Phase 2 study of TPIV 200 in the treatment of triple negative breast cancer.
Finish breast cancer with us from anywhere in the world with Outside Interactive’s Virtual Runner application featuring the DONNA Half Marathon interactive course. Registration is open.
Our gift to you this Anniversary Year, introducing the DONNA App. An app for everyone, make this your complete tool for race training and healthy eating for the 2016 – 2017 training season and beyond.
Learn more »
DONNA partner TapImmune announced its plans to enter into definitive agreements to raise aggregate gross proceeds of approximately $8.5 million from an approximately $2.5 million private placement transaction with new investors and the exercise of certain outstanding warrants from existing investors that will result in gross proceeds of $6 million.
Read more »